Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study
Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study have?
Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study has 201 citations in the OpenAlex counts ScholarIQ stores.
When was Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study published?
Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study has 2020 year in the ScholarIQ index.
What is the open-access status of Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study?
Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study has closed oa status in the ScholarIQ index.
What is the DOI of Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study?
The DOI for Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study is on the source record.
What is the PMID of Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study?
The PMID for Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study is on the source record.
What is the OpenAlex record for Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study?
The OpenAlex for Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study is on the source record.